Johnson & Johnson (J&J) has asked regulators to authorize their COVID-19 vaccine for emergency use in the U.S. and also will apply to authorize to EU, reportedly by media. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)
South will resume its Johnsons &Johnson vaccination programme on Wednesday this is after the rollout was put on hold following cases of rare blood clots that were reported in six recipients in the United States.
BREAKING: South Africa resumes the use of the Johnson and Johnson vaccine. Sisonke trial which is seeing healthcare workers inoculated is also resuming. Vaccination sites will be ex- panded to 95 sites across the country. #VaccineSA #JohnsonandJohnson
— Heidi Giokos (@HeidiGiokos) April 26, 2021
The South African Health Products Regulatory Authority has since found no evidence of blood clots, and health authorities say there is a one in a million chance of getting clotting disorders.
Phase one of the vaccination program, aimed at health workers, is expected to end on 16 May.
Those taking part will be required to give consent again.
Authorities have recommended that pregnant and lactating women be excluded
